Assessment of TB underreporting by level of reporting system in Lagos, Nigeria.
| Autor: | Gidado M; KNCV Tuberculosis Foundation, The Hague, Netherlands., Mitchell EMH; Department of Public Health, Institute for Tropical Medicine, Antwerp, Belgium., Adejumo AO; Mainland Hospital, Yaba, Lagos, Nigeria., Levy J; KNCV Tuberculosis Foundation, The Hague, Netherlands., Emperor O; National TB & Leprosy Control Program, Abuja, Nigeria., Lawson A; National TB & Leprosy Control Program, Abuja, Nigeria., Chukwueme N; New York Medical College, NY, New York., Abdur-Razak H; Health Research Unit, Lagos State Ministry of Health, Lagos, Nigeria., Idris A; Lagos State TB and Leprosy Control Program, Lagos State Ministry of Health, Lagos, Nigeria., Adebowale A; Walden University, Minneapolis, MN, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Public health action [Public Health Action] 2022 Sep 21; Vol. 12 (3), pp. 115-120. |
| DOI: | 10.5588/pha.22.0008 |
| Abstrakt: | Background: Nigeria has an estimated TB prevalence of 219 per 100,000 population. In 2019, Nigeria diagnosed and notified 27% of the WHO-estimated cases of all forms of TB and contributed 11% of the missing TB cases globally. Objective: To assess TB underreporting by type and level of health facility (HF), and associated factors in Lagos State, Nigeria. Methodology: Quantitative secondary data analysis of TB cases was conducted in 2015. χ 2 test was used to assess the association between treatment initiation, TB underreporting, local government area (LGA) and HF characteristics. Results: Overall, 2,064 persons with bacteriologically confirmed TB (15.5%) were not matched to patients in sampled TB registers. Treatment status was unknown for 86 cases (IQR 55-97) per LGA. LGAs with higher case-loads had higher proportions of cases with unknown TB status. Discrepant reporting of treated TB was also common (60% HFs). Primary-level TB treatment facilities and unengaged private facilities were less likely to notify. Conclusion: There was TB under-reporting across all types and levels of HFs and LGAs. There is a need to revise or strengthen the process of supervision and data quality assurance system at all levels. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|